The Translational Pharmacology department at Zealand has an open position for a Research Scientist with experience within in vivo pharmacology as well as ex vivo technologies. The successful candidate will have an interest in working in our established research projects and actively contribute to expanding our portfolio of new early research projects. Support to our clinical projects will also be a part of the job.
As a Scientist in Translational Pharmacology, you will be part of a dedicated team of 19 people consisting of scientists, lab technologists, animal technologists and student assistants. The department is responsible for generating pre-clinical pharmacodynamic in vivo data and mechanistic ex vivo data that can support decision making in our projects and ensure translation to future clinical trials.
Responsibilities
Support to our established research project as Study Director for in-house pharmacology studies and CRO studies. This entails planning, coordination, execution, and reporting of in vivo/ex vivo studies in collaboration with internal/external stakeholders. The position will also require an interest for identifying new potential drug targets and on that background suggest new early research projects.
The successful candidate will be excited by working in teams with talented scientists from other disciplines (e.g., Molecular Pharmacology, Bioanalysis, Pharmaceutical Development and Medical Science). You should therefore possess strong collaborative and written/verbal communication skills and be adept at building partnerships.
Candidate Experience
- Ph.D. in pharmacology or a related discipline of biomedical research.
- FELASA certificate
- Preferable + 2 years postdoc experience (both young and experienced candidates can apply).
- Experience in drug discovery from industry or biotech will be an advantage.
- Scientific knowledge within the metabolic disease area including obesity, dyslipidemia, diabetes, and metabolic comorbidities.
- Experience in developing and working with animal models.
- Experience with indirect calorimetry (TSE) and HM2 feeding system
- Strong scientific approach and statistical analysis skills.
- Experience within different ex vivo techniques (e.g. work with primary cells and their culture, cell lines, organoids and biomarker analysis by flow cytometry, ELISA based assays, COBAS or other relevant methods.
- Confident in interpretation, reporting and publication of study results.
Personal Qualifications
- Open minded and positive attitude.
- A genuine interest in disease biology, biomarker discovery and translational research.
- Excellent communicator, proven ability to build and maintain productive relationships across functions and levels.
- Independent and highly motivated.
What we offer
Our employees are fundamental to our success, and we stive for attracting and retaining people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.
Zealand DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted. Our work environment is characterized by strong cross functional teamwork, room for individual performance and development, informality and respect, high work-ethics and engagement, and fun.
At Zealand, we understand the value of a diverse workforce. As an employee, you will be part of an innovative, cross-disciplinary, and cross-cultural working environment.
Let’s bond and be bold
We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities.
To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/
Application
Please apply no later than December 02, 2024.
For further information, please contact Erik Max Wulff at emw@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.
